Ligand validation:1RTS

D16: TOMUDEX

D16 is a Ligand Of Interest in 1RTS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1RTS_D16_A_309	39%	13%	0.211	0.919	2.24	1.92	11	9	2	0	100%	1
1RTS_D16_B_409	26%	11%	0.24	0.881	2.59	1.8	13	9	0	0	100%	1
4EB4_D16_A_402	79%	11%	0.086	0.931	1.19	3.14	2	11	1	0	100%	1
2TSR_D16_C_509	44%	2%	0.221	0.949	2.98	3.92	10	10	1	0	100%	1
7XYK_D16_D_302	89%	72%	0.076	0.956	0.36	0.68	-	1	0	0	100%	1
6ZXO_D16_B_401	73%	11%	0.125	0.954	1.27	3.07	1	10	2	0	100%	1
8GKF_D16_B_301	71%	52%	0.131	0.954	0.76	1.09	-	2	0	0	100%	1
3NRR_D16_A_530	71%	31%	0.112	0.933	1.59	1.28	5	2	0	0	100%	1
1HVY_D16_D_417	63%	8%	0.122	0.917	1.84	2.91	5	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.